2022 Editorial Calendar

Content themes:

• Industry Radar: Tracking the performance of the global bio/pharmaceutical industry and leading market sectors and the macro issues impacting the industry.
• The CDMO/CMO and Suppliers Report: The keys developments CDMOs/CMOs and suppliers and trends shaping bio/pharmaceutical outsourcing and supply.
• Manufacturing and Supply Lines: The latest from the bio/pharmaceutical/ manufacturing value chain, from raw materials to active pharmaceutical ingredients (small molecules and biologics) to drug products to packaging.
• Supplier Relationship Management:  Industry experts provide lessons learned and best practices for optimizing the bio/pharma company–supplier relationship.
• Special Reports: Special coverage of DCAT webinars and education programs, including programs from DCAT Week as well as other industry-focused reports.

DCAT Value Chain Insights 2022 Editorial Calendar: January-December 2022

January 7	Industry Radar: Bio/Pharma Industry Outlook A market outlook on bio/pharmaceutical industry performance for 2022 and beyond.
January 14	The CDMO/CMO and Suppliers Report: The Year Ahead in Pharma Outsourcing An outlook for bio/pharmaceutical outsourcing for 2022.
January 21	Manufacturing and Supply Lines: The Impact Factors for 2022 Industry experts provide perspective on what they see as the key issues impacting bio/pharma manufacturing and supply in 2022.
January 28	Supplier Relationship Management: What’s Next for 2022? Bio/pharma companies and CDMOs/CMOs weigh in on what they see as the most significant issues shaping supplier relationships in 2022.

February 4	Industry Radar: Small Molecules and Biologics Trend analysis of new molecular entities approvals and breakdown of small molecules and biologics.
February 11	The CDMO/CMO and Suppliers Report: Parenteral Drugs Update of key expansions from CDMOs/CMOs in parenteral drug development and manufacturing.
February 18	Manufacturing and Supply Lines: Fine Chemicals The outlook for fine chemicals supply and demand.
February 25	Special Report: DCAT Week 2022 Preview Special preview of upcoming speakers and education programs at DCAT Week 2022 (March 21 to March 24, 2022).

March 4	Special Report: DCAT Week 2022 Preview Special preview of upcoming speakers and education programs at DCAT Week 2022 (March 21 to March 24, 2022).
March 11	The CDMO/CMO and Suppliers Report: Biomanufacturing Updates on key biomanufacturing expansions by CDMOs/CMOs.
March 18	No issue DCAT Week 2022 (March 21 to March 24, 2022).
March 25	No issue DCAT Week 2022 (March 21 to March 24, 2022).

April 1	Special Report: DCAT Week 2022 in Review Detailed roundup from the DCAT Member Company Announcement Forum and the DCAT Research & Benchmarking Study as presented at DCAT Week 2022.
April 8	Special Report: DCAT Week 2022 in Review Roundup from the education programs at DCAT Week 2022, including a bio/pharmaceutical industry outlook and executive insights.
April 15	Manufacturing and Supply Lines: Clinical Trial Material Supply Industry experts weigh in on the key issues impacting clinical trial material supply, including the future of direct-to-patient supply.
April 22	Supplier Relationship Management: Digitalization Examining how digital tools, such as AI, are and potentially can be applied in supply management of APIs and drug products.
April 29	Special Report: The Global Bio/Pharma Pulse Leading developments from the US, EU, China, India, and Central and South America.

May 6	Industry Radar: Generics and Biosimilars Near-term market outlook for generic drugs and biosimilars and update of key drugs coming off patent.
May 13	The CDMO/CMO and Suppliers Report: Raw Materials Industry experts share perspectives on the issues impacting raw material supply, including energy and transportation inputs.
May 20	Manufacturing and Supply Lines: Manufacturing 4.0 Analysis of key advances in automation and digitalization for bio/pharmaceutical manufacturing and the related market impact.
May 27	Supplier Relationship Management: Orphan Drugs Industry experts provide insight on how to optimize project management for orphan drugs and other low-volume drugs.

June 3	Industry Radar: Blockbuster Muscle Analysis and market projections for new drugs, launched or slated for market entry in 2022, with blockbuster potential.
June 10	The CDMO/CMO and Suppliers Report: What’s Trending in Pharma Outsourcing The key trends and developments in the CDMO/CMO sector.
June 17	Manufacturing and Supply Lines: Small-Molecule APIs Market overview for small-molecule active pharmaceutical ingredients (APIs) and supply–demand fundamentals.
June 24	Supplier Relationship Management: Supplier-Led Innovation Case analysis of supplier-led innovation and how bio/pharma companies and CDMO/CMOs/suppliers brought to fruition.

July 1	Industry Radar: Top Deals in Bio/Pharma M&A A review of the top mergers and acquisitions among bio/pharmaceutical companies thus far in 2022.
July 8	The CDMO/CMO and Suppliers Report: High-Potency APIs Update on expansions by CDMOs/CMOs for high-potency active pharmaceutical ingredient (HPAPI) manufacturing and related trends.
July 15	Manufacturing and Supply Lines: Inside Big Pharma’s Manufacturing Networks The latest manufacturing expansion activity among the bio/pharmaceutical majors.
July 22	Supplier Relationship Management: Talent of the Future Examining evolving skillsets for sourcing professionals for effective supplier relationship management.
July 29	Special Report: Trends in New Drug Approvals Examining the approvals of new molecular entities thus far in 2022, including trends in approvals for small molecules and biologics.

August 5	Industry Radar: Emerging Pharma The start-ups and emerging bio/pharma companies gaining interest from investors and larger pharma companies in partnering deals.
August 12	The CDMO/CMO and Suppliers Report: Formulation Development and Drug Products Latest market and technological advances for solid-dosage and parenteral drugs.
August 19	Manufacturing and Supply Lines: Packaging Industry overview of key trends and developments in primary and secondary packaging.
August 26	Supplier Relationship Management: Post-M&A Integration Best practices managing supplier relationships in integration post mergers and acquisitions.

September 2	Industry Radar: The Innovation Makers The companies, products, and executives leading in bio/pharma product innovation.
September 9	The CDMO/CMO and Suppliers Report: Biomanufacturing Expansions and technology updates in upstream and downstream bioprocessing.
September 16	Manufacturing and Supply Lines: Inside Europe In-depth analysis of key issues impacting the supply of raw materials, intermediates, and APIs in Europe.
September 23	Supplier Relationship Management: Strategic Sourcing Bio/pharmaceutical companies and CDMOs/CMOs offer input on criteria and expectations for becoming a Tier 1 supplier.
September 30	Special Report: Generic Drugs Latest market and regulatory update for generic drugs, including first generic drug approvals in 2022.

October 7	Industry Radar: First-in-Class: Rising Pipeline Contenders Late-stage drug candidates with strong market potential.
October 14	The CDMO/CMO and Suppliers Report: High-Potency Drug Products Update on expansions by CDMOs/CMOs for high-potency drug products and related trends.
October 21	Manufacturing and Supply Lines: API Sourcing Industry roundtable on key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates.
October 28	Supplier Relationship Management: Beyond Traditional Supplier Metrics Industry experts share insights on new metrics for evaluating supplier performance.

November 4	Industry Radar: Cell and Gene Therapies Market outlook and manufacturing expansions for cell and gene therapies.
November 11	The CDMO/CMO and Suppliers Report: Injectable Drugs Industry experts provide insight on key trends and technological developments for injectable drugs, including drug-device technology.
November 18	Manufacturing and Supply Lines: Fine Chemicals Market outlook and key trends in the chemical manufacturing value chain for intermediates and active pharmaceutical ingredients.
November 25	No issue Thanksgiving Holiday.

December 2	Industry Radar: The Bio/Pharma Year in Review A look at the top developments in the bio/pharma industry in 2022.
December 9	The CDMO/CMO and Suppliers Report: The Movers and Shakers of 2022 A look at the top expansions and mergers/acquisitions from CDMOs/CMOs in 2022.
December 16	Manufacturing and Supply Lines: Small-Molecule APIs A look ahead of the key developments from 2022 shaping small-molecule API sourcing in 2023.

There are no issues December 23 and December 30.